Pakistan · Delayed Price · Currency is PKR Sitara Peroxide Statistics
Total Valuation
Sitara Peroxide has a market cap or net worth of PKR 4.21 billion. The enterprise value is 4.62 billion.
| Market Cap | 4.21B |
| Enterprise Value | 4.62B |
Important Dates
The last earnings date was Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sitara Peroxide has 55.10 million shares outstanding. The number of shares has increased by 0.19% in one year.
| Current Share Class | 55.10M |
| Shares Outstanding | 55.10M |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 61.39% |
| Owned by Institutions (%) | n/a |
| Float | 17.45M |
Valuation Ratios
The trailing PE ratio is 23.78.
| PE Ratio | 23.78 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.56 |
| P/TBV Ratio | 3.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 26.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.35, with a Debt / Equity ratio of 0.34.
| Current Ratio | 0.35 |
| Quick Ratio | 0.06 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.54 |
Financial Efficiency
Return on equity (ROE) is 15.78% and return on invested capital (ROIC) is -18.78%.
| Return on Equity (ROE) | 15.78% |
| Return on Assets (ROA) | -6.82% |
| Return on Invested Capital (ROIC) | -18.78% |
| Return on Capital Employed (ROCE) | -21.98% |
| Weighted Average Cost of Capital (WACC) | 8.65% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 13.65M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -136.97M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +550.43% in the last 52 weeks. The beta is 0.81, so Sitara Peroxide's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +550.43% |
| 50-Day Moving Average | 47.48 |
| 200-Day Moving Average | 43.83 |
| Relative Strength Index (RSI) | 66.24 |
| Average Volume (20 Days) | 167,091 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -301.04M |
| Pretax Income | 40.47M |
| Net Income | 177.45M |
| EBITDA | -123.93M |
| EBIT | -301.04M |
| Earnings Per Share (EPS) | 3.22 |
Balance Sheet
The company has 1.03 million in cash and 404.30 million in debt, with a net cash position of -403.27 million or -7.32 per share.
| Cash & Cash Equivalents | 1.03M |
| Total Debt | 404.30M |
| Net Cash | -403.27M |
| Net Cash Per Share | -7.32 |
| Equity (Book Value) | 1.18B |
| Book Value Per Share | 21.48 |
| Working Capital | -804.57M |
Cash Flow
| Operating Cash Flow | -50.89M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 177.11M |
| Net Borrowing | -110.18M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sitara Peroxide does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | -0.19% |
| Earnings Yield | 4.21% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |